nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—Quinapril—Lisinopril—systemic scleroderma	0.459	1	CrCrCtD
Dextropropoxyphene—CYP2C8—Mometasone—systemic scleroderma	0.138	0.406	CbGbCtD
Dextropropoxyphene—CYP2C9—Leflunomide—systemic scleroderma	0.0622	0.183	CbGbCtD
Dextropropoxyphene—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0551	0.162	CbGbCtD
Dextropropoxyphene—CYP2D6—Captopril—systemic scleroderma	0.0446	0.131	CbGbCtD
Dextropropoxyphene—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0223	0.0656	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—systemic scleroderma	0.0179	0.0525	CbGbCtD
Dextropropoxyphene—Bradycardia—Lisinopril—systemic scleroderma	0.000631	0.00316	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisone—systemic scleroderma	0.00063	0.00315	CcSEcCtD
Dextropropoxyphene—Malnutrition—Leflunomide—systemic scleroderma	0.000628	0.00314	CcSEcCtD
Dextropropoxyphene—Confusional state—Captopril—systemic scleroderma	0.000627	0.00314	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Mometasone—systemic scleroderma	0.000623	0.00312	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00062	0.0031	CcSEcCtD
Dextropropoxyphene—Hallucination—Lisinopril—systemic scleroderma	0.000617	0.00309	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000615	0.00308	CcSEcCtD
Dextropropoxyphene—Shock—Captopril—systemic scleroderma	0.000612	0.00306	CcSEcCtD
Dextropropoxyphene—Tachycardia—Captopril—systemic scleroderma	0.000607	0.00304	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000604	0.00303	CcSEcCtD
Dextropropoxyphene—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000599	0.003	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00299	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00297	CcSEcCtD
Dextropropoxyphene—Vision blurred—Leflunomide—systemic scleroderma	0.000592	0.00296	CcSEcCtD
Dextropropoxyphene—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00295	CcSEcCtD
Dextropropoxyphene—Asthenia—Pentoxifylline—systemic scleroderma	0.000589	0.00295	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000587	0.00294	CcSEcCtD
Dextropropoxyphene—Hypotension—Captopril—systemic scleroderma	0.000581	0.00291	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000579	0.0029	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000572	0.00286	CcSEcCtD
Dextropropoxyphene—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000564	0.00283	CcSEcCtD
Dextropropoxyphene—Insomnia—Captopril—systemic scleroderma	0.000562	0.00282	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000561	0.00281	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—systemic scleroderma	0.00056	0.0028	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mometasone—systemic scleroderma	0.00056	0.0028	CcSEcCtD
Dextropropoxyphene—Discomfort—Azathioprine—systemic scleroderma	0.000559	0.0028	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000558	0.0028	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Captopril—systemic scleroderma	0.000554	0.00278	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Lisinopril—systemic scleroderma	0.000554	0.00277	CcSEcCtD
Dextropropoxyphene—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00277	CcSEcCtD
Dextropropoxyphene—Somnolence—Captopril—systemic scleroderma	0.000553	0.00277	CcSEcCtD
Dextropropoxyphene—Agitation—Mycophenolic acid—systemic scleroderma	0.00055	0.00276	CcSEcCtD
Dextropropoxyphene—Quinapril—ACE—systemic scleroderma	0.000548	1	CrCbGaD
Dextropropoxyphene—Dyspepsia—Captopril—systemic scleroderma	0.000547	0.00274	CcSEcCtD
Dextropropoxyphene—Dizziness—Pentoxifylline—systemic scleroderma	0.000542	0.00272	CcSEcCtD
Dextropropoxyphene—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00271	CcSEcCtD
Dextropropoxyphene—Malnutrition—Lisinopril—systemic scleroderma	0.000539	0.0027	CcSEcCtD
Dextropropoxyphene—Syncope—Mycophenolic acid—systemic scleroderma	0.000537	0.00269	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000532	0.00266	CcSEcCtD
Dextropropoxyphene—Constipation—Captopril—systemic scleroderma	0.000532	0.00266	CcSEcCtD
Dextropropoxyphene—Discomfort—Leflunomide—systemic scleroderma	0.000528	0.00264	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000526	0.00264	CcSEcCtD
Dextropropoxyphene—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000523	0.00262	CcSEcCtD
Dextropropoxyphene—Vomiting—Pentoxifylline—systemic scleroderma	0.000522	0.00261	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Prednisone—systemic scleroderma	0.00052	0.0026	CcSEcCtD
Dextropropoxyphene—Convulsion—Mycophenolic acid—systemic scleroderma	0.000519	0.0026	CcSEcCtD
Dextropropoxyphene—Rash—Pentoxifylline—systemic scleroderma	0.000517	0.00259	CcSEcCtD
Dextropropoxyphene—Dermatitis—Pentoxifylline—systemic scleroderma	0.000517	0.00259	CcSEcCtD
Dextropropoxyphene—Headache—Pentoxifylline—systemic scleroderma	0.000514	0.00257	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Captopril—systemic scleroderma	0.000512	0.00257	CcSEcCtD
Dextropropoxyphene—Vision blurred—Lisinopril—systemic scleroderma	0.000508	0.00255	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Captopril—systemic scleroderma	0.000508	0.00255	CcSEcCtD
Dextropropoxyphene—Asthenia—Mometasone—systemic scleroderma	0.000508	0.00254	CcSEcCtD
Dextropropoxyphene—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00254	CcSEcCtD
Dextropropoxyphene—Hypotension—Azathioprine—systemic scleroderma	0.000507	0.00254	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisone—systemic scleroderma	0.000506	0.00253	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00252	CcSEcCtD
Dextropropoxyphene—Discomfort—Mycophenolic acid—systemic scleroderma	0.000504	0.00252	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Leflunomide—systemic scleroderma	0.000502	0.00252	CcSEcCtD
Dextropropoxyphene—Tachycardia—Leflunomide—systemic scleroderma	0.0005	0.0025	CcSEcCtD
Dextropropoxyphene—Confusional state—Mycophenolic acid—systemic scleroderma	0.000493	0.00247	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Captopril—systemic scleroderma	0.000491	0.00246	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000489	0.00245	CcSEcCtD
Dextropropoxyphene—Nausea—Pentoxifylline—systemic scleroderma	0.000487	0.00244	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00243	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mometasone—systemic scleroderma	0.000484	0.00243	CcSEcCtD
Dextropropoxyphene—Syncope—Lisinopril—systemic scleroderma	0.000484	0.00242	CcSEcCtD
Dextropropoxyphene—Shock—Mycophenolic acid—systemic scleroderma	0.000481	0.00241	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000479	0.0024	CcSEcCtD
Dextropropoxyphene—Hypotension—Leflunomide—systemic scleroderma	0.000479	0.0024	CcSEcCtD
Dextropropoxyphene—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000477	0.00239	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Lisinopril—systemic scleroderma	0.000474	0.00237	CcSEcCtD
Dextropropoxyphene—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000473	0.00237	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Methotrexate—systemic scleroderma	0.000469	0.00235	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000468	0.00235	CcSEcCtD
Dextropropoxyphene—Insomnia—Leflunomide—systemic scleroderma	0.000463	0.00232	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Leflunomide—systemic scleroderma	0.000457	0.00229	CcSEcCtD
Dextropropoxyphene—Hypotension—Mycophenolic acid—systemic scleroderma	0.000457	0.00229	CcSEcCtD
Dextropropoxyphene—Discomfort—Lisinopril—systemic scleroderma	0.000454	0.00227	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Leflunomide—systemic scleroderma	0.000451	0.00226	CcSEcCtD
Dextropropoxyphene—Vomiting—Mometasone—systemic scleroderma	0.00045	0.00225	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Azathioprine—systemic scleroderma	0.000447	0.00224	CcSEcCtD
Dextropropoxyphene—Rash—Mometasone—systemic scleroderma	0.000446	0.00223	CcSEcCtD
Dextropropoxyphene—Asthenia—Captopril—systemic scleroderma	0.000446	0.00223	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mometasone—systemic scleroderma	0.000446	0.00223	CcSEcCtD
Dextropropoxyphene—Confusional state—Lisinopril—systemic scleroderma	0.000444	0.00222	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000444	0.00222	CcSEcCtD
Dextropropoxyphene—Headache—Mometasone—systemic scleroderma	0.000443	0.00222	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000442	0.00222	CcSEcCtD
Dextropropoxyphene—Insomnia—Mycophenolic acid—systemic scleroderma	0.000442	0.00221	CcSEcCtD
Dextropropoxyphene—Constipation—Leflunomide—systemic scleroderma	0.000438	0.00219	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000436	0.00218	CcSEcCtD
Dextropropoxyphene—Somnolence—Mycophenolic acid—systemic scleroderma	0.000435	0.00218	CcSEcCtD
Dextropropoxyphene—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00218	CcSEcCtD
Dextropropoxyphene—Shock—Lisinopril—systemic scleroderma	0.000433	0.00217	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00043	0.00215	CcSEcCtD
Dextropropoxyphene—Tachycardia—Lisinopril—systemic scleroderma	0.00043	0.00215	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Azathioprine—systemic scleroderma	0.000429	0.00215	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Captopril—systemic scleroderma	0.000425	0.00213	CcSEcCtD
Dextropropoxyphene—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00212	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Leflunomide—systemic scleroderma	0.000422	0.00211	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000422	0.00211	CcSEcCtD
Dextropropoxyphene—Nausea—Mometasone—systemic scleroderma	0.00042	0.00211	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000419	0.0021	CcSEcCtD
Dextropropoxyphene—Ataxia—Methotrexate—systemic scleroderma	0.000418	0.00209	CcSEcCtD
Dextropropoxyphene—Constipation—Mycophenolic acid—systemic scleroderma	0.000418	0.00209	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00208	CcSEcCtD
Dextropropoxyphene—Hypotension—Lisinopril—systemic scleroderma	0.000411	0.00206	CcSEcCtD
Dextropropoxyphene—Dizziness—Captopril—systemic scleroderma	0.000411	0.00206	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00041	0.00206	CcSEcCtD
Dextropropoxyphene—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00205	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Leflunomide—systemic scleroderma	0.000405	0.00203	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000404	0.00202	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000403	0.00202	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisone—systemic scleroderma	0.000402	0.00201	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Azathioprine—systemic scleroderma	0.0004	0.002	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0004	0.002	CcSEcCtD
Dextropropoxyphene—Insomnia—Lisinopril—systemic scleroderma	0.000398	0.00199	CcSEcCtD
Dextropropoxyphene—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00199	CcSEcCtD
Dextropropoxyphene—Vomiting—Captopril—systemic scleroderma	0.000395	0.00198	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Lisinopril—systemic scleroderma	0.000392	0.00197	CcSEcCtD
Dextropropoxyphene—Rash—Captopril—systemic scleroderma	0.000392	0.00196	CcSEcCtD
Dextropropoxyphene—Dermatitis—Captopril—systemic scleroderma	0.000392	0.00196	CcSEcCtD
Dextropropoxyphene—Somnolence—Lisinopril—systemic scleroderma	0.000391	0.00196	CcSEcCtD
Dextropropoxyphene—Headache—Captopril—systemic scleroderma	0.000389	0.00195	CcSEcCtD
Dextropropoxyphene—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00195	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Lisinopril—systemic scleroderma	0.000388	0.00194	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000386	0.00193	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00038	0.0019	CcSEcCtD
Dextropropoxyphene—Shock—Mycophenolate mofetil—systemic scleroderma	0.000379	0.0019	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000378	0.00189	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Leflunomide—systemic scleroderma	0.000377	0.00189	CcSEcCtD
Dextropropoxyphene—Constipation—Lisinopril—systemic scleroderma	0.000376	0.00189	CcSEcCtD
Dextropropoxyphene—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00189	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisone—systemic scleroderma	0.000375	0.00188	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Azathioprine—systemic scleroderma	0.000371	0.00186	CcSEcCtD
Dextropropoxyphene—Nausea—Captopril—systemic scleroderma	0.000369	0.00185	CcSEcCtD
Dextropropoxyphene—Asthenia—Leflunomide—systemic scleroderma	0.000368	0.00184	CcSEcCtD
Dextropropoxyphene—Hallucination—Prednisone—systemic scleroderma	0.000366	0.00183	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Lisinopril—systemic scleroderma	0.000363	0.00182	CcSEcCtD
Dextropropoxyphene—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00036	0.0018	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00036	0.0018	CcSEcCtD
Dextropropoxyphene—Dizziness—Azathioprine—systemic scleroderma	0.000359	0.0018	CcSEcCtD
Dextropropoxyphene—Asthenia—Mycophenolic acid—systemic scleroderma	0.000351	0.00176	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Leflunomide—systemic scleroderma	0.000351	0.00176	CcSEcCtD
Dextropropoxyphene—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00175	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Lisinopril—systemic scleroderma	0.000348	0.00174	CcSEcCtD
Dextropropoxyphene—Vomiting—Azathioprine—systemic scleroderma	0.000345	0.00173	CcSEcCtD
Dextropropoxyphene—Eye disorder—Prednisone—systemic scleroderma	0.000344	0.00172	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00172	CcSEcCtD
Dextropropoxyphene—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00172	CcSEcCtD
Dextropropoxyphene—Drowsiness—Methotrexate—systemic scleroderma	0.000343	0.00172	CcSEcCtD
Dextropropoxyphene—Rash—Azathioprine—systemic scleroderma	0.000342	0.00171	CcSEcCtD
Dextropropoxyphene—Dermatitis—Azathioprine—systemic scleroderma	0.000342	0.00171	CcSEcCtD
Dextropropoxyphene—Headache—Azathioprine—systemic scleroderma	0.00034	0.0017	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00034	0.0017	CcSEcCtD
Dextropropoxyphene—Dizziness—Leflunomide—systemic scleroderma	0.000339	0.0017	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000334	0.00167	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00167	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Prednisone—systemic scleroderma	0.000332	0.00166	CcSEcCtD
Dextropropoxyphene—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00165	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisone—systemic scleroderma	0.000329	0.00165	CcSEcCtD
Dextropropoxyphene—Vomiting—Leflunomide—systemic scleroderma	0.000326	0.00163	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Lisinopril—systemic scleroderma	0.000324	0.00162	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000324	0.00162	CcSEcCtD
Dextropropoxyphene—Dizziness—Mycophenolic acid—systemic scleroderma	0.000323	0.00162	CcSEcCtD
Dextropropoxyphene—Rash—Leflunomide—systemic scleroderma	0.000323	0.00162	CcSEcCtD
Dextropropoxyphene—Dermatitis—Leflunomide—systemic scleroderma	0.000323	0.00162	CcSEcCtD
Dextropropoxyphene—Nausea—Azathioprine—systemic scleroderma	0.000322	0.00161	CcSEcCtD
Dextropropoxyphene—Headache—Leflunomide—systemic scleroderma	0.000321	0.00161	CcSEcCtD
Dextropropoxyphene—Malnutrition—Prednisone—systemic scleroderma	0.00032	0.0016	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00159	CcSEcCtD
Dextropropoxyphene—Asthenia—Lisinopril—systemic scleroderma	0.000316	0.00158	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00158	CcSEcCtD
Dextropropoxyphene—Vomiting—Mycophenolic acid—systemic scleroderma	0.000311	0.00156	CcSEcCtD
Dextropropoxyphene—Rash—Mycophenolic acid—systemic scleroderma	0.000308	0.00154	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000308	0.00154	CcSEcCtD
Dextropropoxyphene—Headache—Mycophenolic acid—systemic scleroderma	0.000306	0.00153	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00153	CcSEcCtD
Dextropropoxyphene—Nausea—Leflunomide—systemic scleroderma	0.000304	0.00152	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—systemic scleroderma	0.000302	0.00151	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Lisinopril—systemic scleroderma	0.000301	0.00151	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—systemic scleroderma	0.000296	0.00148	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—systemic scleroderma	0.000294	0.00147	CcSEcCtD
Dextropropoxyphene—Dizziness—Lisinopril—systemic scleroderma	0.000291	0.00146	CcSEcCtD
Dextropropoxyphene—Nausea—Mycophenolic acid—systemic scleroderma	0.00029	0.00145	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—systemic scleroderma	0.000287	0.00144	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—systemic scleroderma	0.000287	0.00144	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—systemic scleroderma	0.000285	0.00143	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00142	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—systemic scleroderma	0.000282	0.00141	CcSEcCtD
Dextropropoxyphene—Vomiting—Lisinopril—systemic scleroderma	0.00028	0.0014	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—systemic scleroderma	0.000278	0.00139	CcSEcCtD
Dextropropoxyphene—Rash—Lisinopril—systemic scleroderma	0.000278	0.00139	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—systemic scleroderma	0.000278	0.00139	CcSEcCtD
Dextropropoxyphene—Dermatitis—Lisinopril—systemic scleroderma	0.000277	0.00139	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000277	0.00139	CcSEcCtD
Dextropropoxyphene—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00139	CcSEcCtD
Dextropropoxyphene—Headache—Lisinopril—systemic scleroderma	0.000276	0.00138	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—systemic scleroderma	0.000269	0.00135	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—systemic scleroderma	0.000268	0.00134	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00132	CcSEcCtD
Dextropropoxyphene—Nausea—Lisinopril—systemic scleroderma	0.000261	0.00131	CcSEcCtD
Dextropropoxyphene—Shock—Prednisone—systemic scleroderma	0.000257	0.00129	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—systemic scleroderma	0.000256	0.00128	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisone—systemic scleroderma	0.000255	0.00128	CcSEcCtD
Dextropropoxyphene—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00128	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—systemic scleroderma	0.000252	0.00126	CcSEcCtD
Dextropropoxyphene—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00123	CcSEcCtD
Dextropropoxyphene—Rash—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00122	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00122	CcSEcCtD
Dextropropoxyphene—Headache—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00121	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—systemic scleroderma	0.000236	0.00118	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—systemic scleroderma	0.000232	0.00116	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—systemic scleroderma	0.00023	0.00115	CcSEcCtD
Dextropropoxyphene—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00115	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—systemic scleroderma	0.000225	0.00113	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—systemic scleroderma	0.000224	0.00112	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—systemic scleroderma	0.00022	0.0011	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—systemic scleroderma	0.000215	0.00108	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—systemic scleroderma	0.000214	0.00107	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000214	0.00107	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Prednisone—systemic scleroderma	0.000207	0.00104	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—systemic scleroderma	0.000204	0.00102	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—systemic scleroderma	0.000198	0.00099	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—systemic scleroderma	0.000195	0.000976	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—systemic scleroderma	0.000194	0.000973	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisone—systemic scleroderma	0.000193	0.000965	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—systemic scleroderma	0.000192	0.000963	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000189	0.000945	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—systemic scleroderma	0.000188	0.000939	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—systemic scleroderma	0.00018	0.000902	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Prednisone—systemic scleroderma	0.000179	0.000896	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000179	0.000895	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisone—systemic scleroderma	0.000173	0.000866	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—systemic scleroderma	0.000173	0.000865	CcSEcCtD
Dextropropoxyphene—Vomiting—Prednisone—systemic scleroderma	0.000166	0.000833	CcSEcCtD
Dextropropoxyphene—Rash—Prednisone—systemic scleroderma	0.000165	0.000826	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—systemic scleroderma	0.000165	0.000825	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—systemic scleroderma	0.000164	0.00082	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—systemic scleroderma	0.000161	0.000806	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—systemic scleroderma	0.000157	0.000785	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisone—systemic scleroderma	0.000155	0.000778	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—systemic scleroderma	0.00015	0.000749	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—systemic scleroderma	0.000144	0.000724	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—systemic scleroderma	0.000139	0.000696	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—systemic scleroderma	0.000138	0.00069	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—systemic scleroderma	0.000138	0.000689	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—systemic scleroderma	0.000137	0.000686	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—systemic scleroderma	0.00013	0.00065	CcSEcCtD
